The Epidemic Status and Development Trend of Hepatitis C Virus Infection in Pregnant Women in Xi'an

N/ANot Yet RecruitingNCT06952036

First Affiliated Hospital Xi'an Jiaotong University200,000 enrolled

Overview

The objectives of this study are to improve HCV linkage-to-care in Chinese women and provide theoretical basis for the scientific formulation of HCV prevention and control strategies for pregnant women. To understand the epidemiological changes and status of hepatitis C virus (HCV) infection in pregnant women in Shaanxi province in recent 10 years, and to analyze the main influencing factors of hepatitis C infection in pregnant women.

Study Type

OBSERVATIONAL

Enrollment

200,000

Conditions

HCV Infection HCV Elimination

Interventions

Standard Direct-acting antivirals (DAA) treatment procedures for patients with hepatitis CPROCEDURE

Initiated Standard DAA treatment among HCV RNA positive patients.

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Pregnant women or parturient women confirmed by blood HCG test. 2. Patients aged 18 years old and above. 3. Patients with HCV antibody seropositive or HCV RNA positive from 2014-2023. Exclusion Criteria: 1. Patients without valid telephone numbers. 2. Duplicate records: For duplicate records of the same pregnant woman, only one record should be kept.

Outcomes

Primary Outcomes

Relink rate

The percentage of patients receiving DAA treatment among the diagnosed but untreated patients.

Time frame: From enrollment to the end of treatment at 12 weeks

Central Contacts

Yingli He

CONTACT

+86-18991232863 heyingli2000@xjtu.edu.cn

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.